-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Solid organ transplant (SOT) recipients are at high risk of contracting the new coronavirus.
According to reports, the hospital mortality of these patients is between 20% and 30%
.
Although the new crown viral infection associated with serious co-morbidities such as heart vascular disease, obesity, hypertension and diabetes , etc.
are common in this population, but it is not clear observed in the general population immunity if there are changes in response SOT patients
Solid organ transplant (SOT) recipients are at high risk of contracting the new coronavirus.
In this retrospective study, the researchers compared the peripheral blood T and B cell function, surface markers and serum antibody levels in 29 mild and 22 severe COVID-19 patients in solid organ transplants (72% kidney transplants).
Development
In this retrospective study, the researchers compared the peripheral blood T and B cell function, surface markers and serum antibody levels in 29 mild and 22 severe COVID-19 patients in solid organ transplants (72% kidney transplants).
The results of the study showed that the CD3D and CD8D T cell counts of patients with severe COVID-19 were significantly reduced
Comparison of T cells (Treg) in 2019 young and severe coronavirus diseases
Comparison of T cells (Treg) in 2019 young and severe coronavirus disease T cells (Treg) in 2019 young and severe coronavirus disease comparison T cell (Treg) in 2019 young and severe coronavirus disease CompareThere is a difference in the expression of T cell and B cell markers in patients with mild symptoms and those with mild symptoms and later developments
.
There is a difference in the expression of T cell and B cell markers in patients with mild symptoms and those with mild symptoms and later developments
All in all, this data shows a huge difference between light and severe COVID-19 infections, similar to what is observed in the general population
Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation in this message
